Akụkọ ụlọ ọrụ
-
Daalụ!!
Na-ekele na anyị, Changzhou Pharmaceutical Factory anatawo Asambodo Ndebanye aha Ngwaahịa site na Republic of Philippines Department of Health maka mbadamba Rosuvastatin anyị (5mg, 10mg, 20mg, 40mg), na ndebanye aha NO. bụ DR-XY48615, DR-XY48616, DR-XY...GỤKWUO -
Ihe niile gbasara HYDROCHLOROTHIAZIDE
Ndị na-emepụta Hydrochlorothiazide na-akọwa ihe niile dị mkpa gbasara hydrochlorothiazide iji nyere gị aka ịmata ya nke ọma. Kedu ihe bụ hydrochlorothiazide? Hydrochlorothiazide (HCTZ) bụ thiazide diuretic nke na-enyere aka gbochie ahụ gị ịrapara oke nnu, nke nwere ike ...GỤKWUO -
Ezubere iche ọgwụ maka ọgwụgwọ nke myelofibrosis: Ruxolitinib
A na-akpọ Myelofibrosis (MF) dị ka myelofibrosis. Ọ bụkwa ọrịa na-adịghị ahụkebe. Na ihe kpatara ya pathogenesis amaghị. Ngosipụta ụlọ ọgwụ a na-ahụkarị bụ mkpụrụ ndụ ọbara uhie na-eto eto na granulocytic anaemia na-eto eto nwere ọnụ ọgụgụ dị elu nke anya mmiri na-adaba mkpụrụ ndụ ọbara uhie.GỤKWUO -
Ị kwesịrị ịma ma ọ dịkarịa ala isi ihe atọ ndị a gbasara rivaroxaban
Dị ka ọgwụ mgbochi ọnụ ọhụrụ, Rivaroxaban ejiriwo ya mee ihe n'ọtụtụ ebe na mgbochi na ọgwụgwọ ọrịa thromboembolic venous na mgbochi ọrịa strok na-adịghị valvular atrial fibrillation. Iji jiri rivaroxaban mee ihe n'ụzọ ziri ezi, ị kwesịrị ịma ma ọ dịkarịa ala isi ihe atọ ndị a....GỤKWUO -
Changzhou Pharmaceutical nwetara nkwado iji mepụta Capsules Lenalidomide
Changzhou Pharmaceutical Factory Ltd., onye enyemaka nke Shanghai Pharmaceutical Holdings, natara akwụkwọ ndebanye aha ọgwụ ọjọọ (Asambodo Mba 2021S01077, 2021S01078, 2021S01078, 2021S01079) nyere site na State Drug Administration maka Lenali5mgide.GỤKWUO -
Kedu ihe kpachara anya maka mbadamba nkume Rivaroxaban?
Rivaroxaban, dị ka ọgwụ mgbochi ọnụ ọhụrụ, ejirila ya mee ihe n'ọtụtụ ebe na mgbochi na ọgwụgwọ nke ọrịa thromboembolic venous. Kedu ihe m kwesịrị ịṅa ntị na mgbe ị na-ewere rivaroxaban? N'adịghị ka warfarin, rivaroxaban anaghị achọ nleba anya nke clotting ọbara na-egosi ...GỤKWUO -
2021 FDA kwadoro ọgwụ ọhụrụ 1Q-3Q
Ihe ọhụrụ na-akwalite ọganihu. Mgbe a bịara n'ihe ọhụrụ na mmepe nke ọgwụ ọhụrụ na ngwaahịa ọgwụgwọ ọgwụgwọ, FDA's Center for Drug Evaluation and Research (CDER) na-akwado ụlọ ọrụ ọgwụ na usoro ọ bụla. Na nghọta ya nke ...GỤKWUO -
Mmelite nke Sugammadex Sodium na nso nso a n'oge anesthesia
Sugammadex Sodium bụ onye mmegide ọhụụ nke ndị na-ahụ maka ahụ ike na-adịghị emebi emebi (myorelaxants), bụ nke mbụ a kọrọ n'ime mmadụ na 2005 ma ejirila ya na Europe, United States na Japan. Tụnyere ọgwụ anticholinesterase ọdịnala...GỤKWUO -
Kedu etuto ndị thalidomide dị irè n'ịgwọ!
Thalidomide dị irè n'ịgwọ etuto ndị a! 1. Na nke siri ike etuto nwere ike iji thalidomide. 1.1. ọrịa cancer akpa ume. 1.2. Ọrịa prostate. 1.3. nodal rectal cancer. 1.4. hepatocellular carcinoma. 1.5. Ọrịa kansa afọ. ...GỤKWUO -
Ihe ngosi Guangzhou API na 2021
Ihe ngosi nke 86 nke China International Pharmaceutical Raw Materials/ Intermediates/Package/Equipment Fair (API China for short) Onye nhazi: Reed Sinopharm Exhibition Co., Ltd. Oge ngosi: Mee 26-28, 2021 Ebe: China Import and Export Fair Complex (Guangzhou) Ngosipụta ọnụ ọgụgụ: 60,000 square mita Ex ...GỤKWUO -
Obeticolic acid
Na June 29, Intercept Pharmaceuticals kwupụtara na ọ natala ngwa ọgwụ ọhụrụ zuru oke site na US FDA gbasara FXR agonist obeticholic acid (OCA) maka fibrosis nke steatohepatitis na-abụghị mmanya kpatara (NASH) leta nzaghachi (CRL). FDA kwuru na CRL nke dabere na data ...GỤKWUO -
Remdesivir
Na Ọktọba 22, n'oge ọwụwa anyanwụ, US FDA kwadoro ọgwụ mgbochi nke Gilied Veklury (remdesivir) maka ojiji na ndị okenye gbara afọ 12 gbagoro ma tụọ opekata mpe 40 n'arọ nke chọrọ ụlọ ọgwụ na ọgwụgwọ COVID-19. Dabere na FDA, Veklury bụ ugbu a naanị FDA kwadoro COVID-19 t…GỤKWUO